drugset / Trial / NCT03768388

Levoketoconazole Food Effect Study in Healthy Subjects

NCT03768388

Phase 1 Completed 22 enrolled Cortendo AB
RandomizedCrossoverOpen-labelOther

Summary

This is a phase I, randomized, open-label, single-dose, two-period, two-sequence crossover study in healthy male and female subjects to evaluate the effect of food on the PK of levoketoconazole.

Timeline

Start
2018-11-30
Primary completion
2018-12-24
Completion
2018-12-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Levoketoconazole Unknown 600 mg Oral

Indications

No indication recorded.